Laterza, Lucrezia
 Distribuzione geografica
Continente #
NA - Nord America 2.487
EU - Europa 2.408
AS - Asia 2.228
SA - Sud America 570
AF - Africa 56
OC - Oceania 13
Continente sconosciuto - Info sul continente non disponibili 4
Totale 7.766
Nazione #
US - Stati Uniti d'America 2.388
SG - Singapore 1.084
DE - Germania 593
CN - Cina 559
IT - Italia 482
BR - Brasile 474
SE - Svezia 351
PL - Polonia 197
FR - Francia 181
GB - Regno Unito 127
VN - Vietnam 123
UA - Ucraina 105
IE - Irlanda 91
FI - Finlandia 88
ID - Indonesia 86
IN - India 85
CA - Canada 49
HK - Hong Kong 44
RU - Federazione Russa 43
AR - Argentina 42
KR - Corea 41
BD - Bangladesh 34
TR - Turchia 34
MX - Messico 32
NL - Olanda 31
JP - Giappone 27
IQ - Iraq 25
ES - Italia 22
BE - Belgio 21
ZA - Sudafrica 19
AT - Austria 18
EC - Ecuador 13
IR - Iran 13
SA - Arabia Saudita 12
AU - Australia 11
CZ - Repubblica Ceca 11
PK - Pakistan 9
VE - Venezuela 9
CL - Cile 8
CO - Colombia 8
CI - Costa d'Avorio 7
PY - Paraguay 7
RO - Romania 7
UZ - Uzbekistan 7
DZ - Algeria 6
EG - Egitto 6
JM - Giamaica 6
LT - Lituania 6
PH - Filippine 6
AE - Emirati Arabi Uniti 5
HU - Ungheria 5
KE - Kenya 5
KZ - Kazakistan 5
TN - Tunisia 5
AZ - Azerbaigian 4
BG - Bulgaria 4
CH - Svizzera 4
IL - Israele 4
MA - Marocco 4
PT - Portogallo 4
UY - Uruguay 4
BO - Bolivia 3
DO - Repubblica Dominicana 3
EU - Europa 3
JO - Giordania 3
LV - Lettonia 3
OM - Oman 3
AL - Albania 2
BH - Bahrain 2
BY - Bielorussia 2
KG - Kirghizistan 2
MD - Moldavia 2
MY - Malesia 2
PA - Panama 2
PE - Perù 2
AO - Angola 1
BA - Bosnia-Erzegovina 1
BN - Brunei Darussalam 1
CR - Costa Rica 1
CY - Cipro 1
DM - Dominica 1
EE - Estonia 1
GH - Ghana 1
GR - Grecia 1
GT - Guatemala 1
HN - Honduras 1
HR - Croazia 1
KH - Cambogia 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LY - Libia 1
ME - Montenegro 1
MM - Myanmar 1
NI - Nicaragua 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PR - Porto Rico 1
PS - Palestinian Territory 1
PW - Palau 1
RS - Serbia 1
Totale 7.760
Città #
Singapore 539
Chandler 336
Ashburn 283
Warsaw 168
Beijing 118
Hefei 100
New York 99
Rome 98
Los Angeles 91
Dublin 88
Jakarta 73
Munich 71
Jacksonville 69
Ann Arbor 68
Milan 66
San Mateo 62
Dallas 61
São Paulo 56
Cattolica 54
The Dalles 52
Frankfurt am Main 50
Ho Chi Minh City 45
Boston 44
Hong Kong 42
Wilmington 40
Seoul 39
Nanjing 36
Helsinki 33
Hanoi 31
Woodbridge 30
Houston 29
Kent 29
Buffalo 28
Moscow 28
Boardman 27
Dearborn 27
Fairfield 25
Marseille 25
North Bergen 24
Nürnberg 24
Hyderabad 22
Lawrence 22
Seattle 22
Chicago 21
Nuremberg 21
Tokyo 21
Brooklyn 19
Turku 19
Brussels 18
Princeton 18
Santa Clara 18
Izmir 17
London 17
Stockholm 17
Chennai 15
Düsseldorf 15
Kraków 15
Lancaster 15
Denver 14
Lappeenranta 14
Poplar 14
Redwood City 14
Bremen 13
Mexico City 13
Montreal 13
Toronto 13
Baghdad 12
Phoenix 12
Tianjin 12
Belo Horizonte 11
Manchester 11
Monza 11
Mountain View 11
Shenyang 11
Fremont 10
Hangzhou 10
Johannesburg 10
Lauterbourg 10
Macerata 10
Naples 10
Orem 10
Porto Alegre 10
Rio de Janeiro 10
Roubaix 10
Salvador 10
Shanghai 10
Atlanta 9
Hebei 9
Nanchang 9
Paris 9
San Francisco 9
Vienna 9
Kish 8
Portsmouth 8
Wroclaw 8
Abidjan 7
Amsterdam 7
Ankara 7
Brasília 7
Cambridge 7
Totale 3.972
Nome #
Gut microbial flora, prebiotics, and probiotics in IBD: their current usage and utility 336
Irritable bowel syndrome and nickel allergy: What is the role of the low nickel diet? 199
Propionyl-L-carnitine hydrochloride for treatment of mild to moderate colonic inflammatory bowel diseases 188
13C-octanoic acid breath test to study gastric emptying time 171
Efficacy and Mechanisms of Action of Fecal Microbiota Transplantation in Ulcerative Colitis: Pitfalls and Promises From a First Meta-Analysis 168
Comparison between clinical and radiological evaluation before and after medical therapy in patients with Crohn's disease: new prospective roles of CT enterography 156
Comparison between clinical and radiological evaluation before and after medical therapy in patients with Crohn's disease: new prospective roles of CT enterography 149
Comparison of performances of infliximab biosimilars CT-P13 versus SB2 in the treatment of inflammatory bowel diseases: a real-life multicenter, observational study in Italy 139
Erratum to: Binge Drinking among adolescents is related to the development of Alcohol Use Disorders: results from a Cross-Sectional Study (Scientific Reports, (2018), 8, 1, (12624), 10.1038/s41598-018-29311-y) 131
Binge Drinking among adolescents is related to the development of Alcohol Use Disorders: results from a Cross-Sectional Study 129
Gut microbial flora, prebiotics and probiotics in IBD: their current usage and utility 128
Role of yeasts in healthy and impaired gut microbiota: the gut mycome 128
Circulating hematopoietic stem cells and putative intestinal stem cells in coeliac disease 128
Intestinal gas production and gastrointestinal symptoms: from pathogenesis to clinical implication 127
Tricks for interpreting and making a good report on hydrogen and 13C breath tests 126
Body mass index influences infliximab post-infusion levels and correlates with prospective loss of response to the drug in a cohort of inflammatory bowel disease patients under maintenance therapy with Infliximab 125
Diet-Induced Alterations in Gut Microbiota Composition and Function 122
Rifaximin for the treatment of diarrhoea-predominant irritable bowel syndrome 121
Nodular lymphoid hyperplasia: A marker of low-grade inflammation in irritable bowel syndrome? 121
Origin of celiac disease: How old are predisposing haplotypes? 117
Gut microbial flora, prebiotics, and probiotics in IBD: their current usage and utility 114
Gastrointestinal motility disorder assessment in systemic sclerosis 113
Intestinal Permeability and Dysbiosis in Female Patients with Recurrent Cystitis: A Pilot Study 111
Transition from intravenous to subcutaneous biological therapies in inflammatory bowel disease: An online survey of patients 110
Pancreatic function assessment 107
The Microbiota-Gut-Brain Axis: Psychoneuroimmunological Insights 106
Microparticles produced by activated platelets carry a potent and functionally active angiogenic signal in subjects with crohn’s disease 105
Multiparametric Evaluation Predicts Different Mid-Term Outcomes in Crohn's Disease 101
Case report: Dupilumab treatment improved type 2 disorders in a patient with IPEX syndrome diagnosis 100
Gut and reproductive tract microbiota adaptation during pregnancy: New insights for pregnancy-related complications and therapy 99
Gastrointestinal motility disorder assessment in systemic sclerosis 98
Epidemiology of inflammatory bowel disease in the Republic of San Marino: The “EPIMICI – San Marino” study 96
Impact of COVID-19 pandemic on the daily management of biotechnological therapy in inflammatory bowel disease patients: Reorganisational response in a high-volume Italian inflammatory bowel disease centre 96
Secretome modulation of Caco-2 cell line induced by a multi-strain probiotic 95
Impact of SARS-CoV-2 Infection on the Course of Inflammatory Bowel Disease in Patients Treated with Biological Therapeutic Agents: A Case-Control Study. 95
Fibrostenosing Crohn's Disease: Pathogenetic Mechanisms and New Therapeutic Horizons 93
Effect of a multistrain probiotic on leaky gut in patients with diarrhea-predominant irritable bowel syndrome (IBS-D): a pilot study 92
Crohn's Disease: Radiological Answers to Clinical Questions and Review of the Literature 91
Popular diets and nutritional assessment in the management of irritable bowel syndrome in inflammatory bowel disease: an overview of current evidence 90
Radiomics could predict surgery at 10 years in Crohn's disease 90
Bowel contrast-enhanced ultrasound perfusion imaging in the evaluation of Crohn's disease patients undergoing anti-TNFα therapy 89
Ecology and Machine Learning-Based Classification Models of Gut Microbiota and Inflammatory Markers May Evaluate the Effects of Probiotic Supplementation in Patients Recently Recovered from COVID-19 88
Impact of the Trophic Effects of the Secretome from a Multistrain Probiotic Preparation on the Intestinal Epithelia 88
Addressing Nutritional Knowledge Gaps in Inflammatory Bowel Disease: A Scoping Review 87
Serial Fecal Microbiota Infusions via Colonoscopy for Active Ulcerative Colitis: A Feasibility, Safety, and Translational Monocentric Italian Study 87
Eluxadoline for the treatment of diarrhoea-predominant irritable bowel syndrome 87
Cellular and Molecular Determinants of Biologic Drugs Resistance and Therapeutic Failure in Inflammatory Bowel Disease 86
Cytomegalovirus Infection: An Underrated Target in Inflammatory Bowel Disease Treatment 85
Histologic Disease Persists beyond Mucosal Healing and Could Predict Reactivation in Ulcerative Colitis 85
Effectiveness and safety of vedolizumab in a matched cohort of elderly and nonelderly patients with inflammatory bowel disease: the IG‐IBD LIVE study 80
Extracellular Vesicles: Novel Potential Therapeutic Agents in Inflammatory Bowel Diseases 78
Clinical value of alarm features for colorectal cancer: A meta-analysis 77
Evaluation of tolerability and major factors affecting the adherence to probiotic therapy in patients with irritable bowel syndrome: a prospective, observational, real-life study 77
THE GUT MICROBIOTA AND IMMUNE SYSTEM RELATIONSHIP IN HUMAN GRAFT-VERSUS-HOST DISEASE 76
SECRETOME MODULATION OF CACO2 CELL LINE INDUCED BY A MULTI-STRAIN PROBIOTIC 76
Inflammatory Bowel Diseases and Non-Alcoholic Fatty Liver Disease: Piecing a Complex Puzzle Together 75
Clinical value of alarm features for colorectal cancer: A meta-analysis 75
Bariatric procedures and microbiota: patient selection and outcome prediction 74
Factors That Affect Adequacy of Colon Cleansing for Colonoscopy in Hospitalized Patients 73
Review Article: Green Management of IBD—New Paradigms for an Eco-Friendly Approach 70
Clinical, Radiological, and Surgical Risk Factors for Endoscopic Anastomotic Recurrence Following Surgery in Crohn's Disease 68
The Microbiota-Gut-Brain Axis: Psychoneuroimmunological Insights 67
Factors That Affect Adequacy of Colon Cleansing for Colonoscopy in Hospitalized Patients 66
PET in inflammatory bowel diseases: a new FAPI era? 65
Clinical Trial IBD Unit: The Role of the Study Nurse in Conduction of Trials and Patients' Care 63
Gut and reproductive tract microbiota adaptation during pregnancy: New insights for pregnancy-related complications and therapy 63
How to identify patients who are less likely to have metachronous neoplasms after a colon cancer: A predictive model 62
Gut microbiota during dietary restrictions: New insights in non-communicable diseases 62
Risk factors for gastric cancer: is it time to discard PPIs? 61
Systematic review with meta-analysis: the appropriateness of colonoscopy increases the probability of relevant findings and cancer while reducing unnecessary exams 60
Vascular complications in hospitalized patients with inflammatory bowel disease and acute gastroenteritis and colitis: A propensity score-matched study 59
Higher adenoma recurrence rate after left- versus right-sided colectomy for colon cancer 56
Effectiveness and Safety of Switching from Intravenous to Subcutaneous Vedolizumab Formulation in Inflammatory Bowel Disease Patients in Clinical Remission 56
Multimodal dynamic ultrasound approach as predictor of response in patients with Crohn’s disease treated with ustekinumab 52
1L- vs. 4L-Polyethylene glycol for bowel preparation before colonoscopy among inpatients: A propensity score-matching analysis 52
The diagnostic yield of colonoscopy in hospitalized patients. An observational multicenter prospective study 52
Nonmedical switch of anti-TNF-α biosimilars has no major clinical, pharmacokinetic and psychological impact on patients with IBD - the SAFER Study 51
1L- vs. 4L-Polyethylene glycol for bowel preparation before colonoscopy among inpatients: A propensity score-matching analysis 49
Systematic review with meta-analysis: the appropriateness of colonoscopy increases the probability of relevant findings and cancer while reducing unnecessary exams 46
The diagnostic yield of colonoscopy in hospitalized patients. An observational multicenter prospective study 45
Cancer Risk in IBD Patients Treated with JAK Inhibitors: Reassuring Evidence from Trials and Real-World Data 45
Onset of ulcerative colitis after thyrotoxicosis: a case report and review of the literature 44
Totale 7.868
Categoria #
all - tutte 34.492
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 34.492


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021166 0 0 0 0 0 17 32 6 30 16 57 8
2021/2022364 15 25 5 14 22 16 6 71 14 51 56 69
2022/2023930 108 126 79 136 58 101 55 79 93 36 40 19
2023/2024728 25 125 51 46 42 108 50 19 46 34 82 100
2024/20251.843 27 42 147 52 139 63 116 78 181 238 422 338
2025/20262.495 615 195 330 578 737 40 0 0 0 0 0 0
Totale 7.868